Glenmark Pharma shares up 2% after FDA grants fast track status to cancer drug
Glenmark Pharmaceuticals shares climbed as much as 1.8% on Tuesday to Rs 1,431.25 on the BSE after the company announced that its innovation arm, Ichnos Glenmark Innovation (IGI), has received…
